ALVEOLAR SOFT PART SARCOMA
Clinical trials for ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell combo aims to fight stubborn childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid. The goal is to help the donor cells attack the tumor without causing severe side effects. It is for children and young adults a…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
New drug combo shows promise for rare sarcoma in early trial
Disease control Recruiting nowThis study tests a combination of two drugs (benmelstobart and anlotinib) in people aged 14 and older with advanced or inoperable alveolar soft part sarcoma, a rare soft tissue cancer. The main goal is to see if the treatment shrinks tumors. About 33 participants will receive the…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 01:46 UTC
-
New hope for rare sarcoma: phase 3 drug trial now recruiting
Disease control Recruiting nowThis study tests a drug called AL3818 (anlotinib) for people with a rare cancer called alveolar soft part sarcoma that has spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors or slow cancer growth. Participants take AL3818 pills daily, and the…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Targeted limb infusion plus immunotherapy may delay sarcoma progression
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to chemotherapy drugs (melphalan and dactinomycin) delivered directly to the affected arm or leg can safely delay cancer growth. About 30 people with advanced or spreading sarcoma in a limb will take part. The g…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Scientists dive deep into rare sarcomas to unlock immune secrets
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system's role in rare soft tissue sarcomas. Researchers will collect and analyze blood and tumor samples from 400 patients with these uncommon cancers. The goal is to find patterns that could help predict how the disease will progres…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC